The estimated Net Worth of John Charles Rademacher is at least $23.7 Million dollars as of 21 February 2024. Mr. Rademacher owns over 11,087 units of Option Care Health stock worth over $22,891,559 and over the last 4 years he sold OPCH stock worth over $0. In addition, he makes $856,179 as Chief Executive Officer und Director at Option Care Health.
John has made over 3 trades of the Option Care Health stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 11,087 units of OPCH stock worth $359,551 on 21 February 2024.
The largest trade he's ever made was exercising 11,087 units of Option Care Health stock on 21 February 2024 worth over $359,551. On average, John trades about 3,217 units every 102 days since 2021. As of 21 February 2024 he still owns at least 705,876 units of Option Care Health stock.
You can see the complete history of Mr. Rademacher stock trades at the bottom of the page.
John Charles Rademacher serves as Chief Executive Officer, Director of the Company. He served on the legacy Option Care board from 2018 until the Merger. Mr. Rademacher is the Chief Executive Officer of Option Care, a position he has held since August 2017. Prior to his appointment as Chief Executive Officer, Mr. Rademacher was Option Care’s Chief Operating Officer from 2015 until he became interim Chief Executive Officer. Prior to his roles at Option Care, Mr. Rademacher was the President and General Manager for both the Ambulatory Care Division from 2012 to 2014 and Nuclear and Pharmacy Services division from 2007 to 2012 at Cardinal Health, Inc., a publicly traded pharmaceutical company. Mr. Rademacher also held executive positions with CIGNA Corporation, a publicly traded health services company, from 2001 to 2007 where he served as president of CareAllies, LLC and Chief Operating Officer for CIGNA Behavioral Health business units among other roles. Prior to CIGNA, Mr. Rademacher was a strategy consultant for Deloitte Consulting. Mr. Rademacher holds an M.B.A. from Wayne State University and a B.A. in accounting from Hillsdale College. Mr. Rademacher’s extensive understanding of Option Care’s business and over 20 years of experience in the healthcare industry make him a valuable member of our Board.
As the Chief Executive Officer und Director of Option Care Health, the total compensation of John Rademacher at Option Care Health is $856,179. There are 3 executives at Option Care Health getting paid more, with Harriet Booker having the highest compensation of $1,393,652.
John Rademacher is 53, he's been the Chief Executive Officer und Director of Option Care Health since 2019. There are 14 older and 5 younger executives at Option Care Health. The oldest executive at Option Care Health, Inc. is John Arlotta, 70, who is the Independent Director.
John's mailing address filed with the SEC is C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN, IL, 60015.
Over the last 5 years, insiders at Option Care Health have traded over $6,426,460,535 worth of Option Care Health stock and bought 202,320 units worth $5,246,552 . The most active insiders traders include Timothy P Sullivan, Elizabeth Quadros Betten und Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of $157,254,886. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth $47,422.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health executives and other stock owners filed with the SEC include: